Literature DB >> 10769289

Role of the Na(+)/H(+) exchanger in short-term atrial electrophysiological remodeling.

J V Jayachandran1, D P Zipes, J Weksler, J E Olgin.   

Abstract

BACKGROUND: The pathophysiology underlying electrophysiological remodeling (ER) from rapid atrial rates is unknown. We tested the hypothesis that activation of the Na(+)/H(+) exchanger (NHE) by ischemia contributes to ER. METHODS AND
RESULTS: Twenty-eight dogs were studied under autonomic blockade. In 15 closed-chest dogs, atrial fibrillation was simulated by right atrial pacing at 600 bpm over 5 hours. Of these, 9 (pace/NHEI) received HOE642, a selective inhibitor of the NHE, and 6 (pace/control) received saline. In pace/controls, atrial effective refractory period (AERP) at a drive cycle length (DCL) of 400 ms shortened from 143+/-7 to 118+/-5 ms (1 hour) and to 122+/-17 ms (5 hours). Shortening of AERP was prevented in the pace/NHEI group (P=0.02 compared with pace/controls). At baseline in all 15 dogs, pacing at shorter DCL resulted in shortening of AERP (physiological rate adaptation), which was lost at 5 hours in pace/controls. In pace/NHEI animals, rate adaptation was maintained despite 5 hours of pacing (P=0.02). In 13 other open-chest dogs, right atrial ERP was determined before and after occlusion of the right coronary artery. Five received HOE642 (ischemia/NHEI), 5 saline (ischemia/control), and 3 intravenous glibenclamide. In ischemia/controls, AERP(400) decreased (156+/-30 to 130+/-32 ms). Shortening of AERP was not prevented by glibenclamide (180+/-20 to 153+/-33 ms) but was prevented in ischemia/NHEI dogs (169+/-12 to 184+/-19 ms, P=0.001 compared with ischemia/controls and ischemia/glibenclamide). Rate adaptation was lost in ischemia/controls and preserved in ischemia/NHEI dogs (P=0. 02).
CONCLUSIONS: Activation of the NHE is one mechanism underlying short-term ER.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769289     DOI: 10.1161/01.cir.101.15.1861

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Proteomics and transcriptomics in atrial fibrillation.

Authors:  Marc Sühling; Carmen Wolke; Christian Scharf; Uwe Lendeckel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-09

Review 2.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

3.  Remodeling of atrial ATP-sensitive K⁺ channels in a model of salt-induced elevated blood pressure.

Authors:  Joshua M Lader; Carolina Vasquez; Li Bao; Karen Maass; Jiaxiang Qu; Eirini Kefalogianni; Glenn I Fishman; William A Coetzee; Gregory E Morley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-01       Impact factor: 4.733

Review 4.  Cardiac Events Theoretically Cannot Be Produced By Non-Ischemic And/Or Iso-Ischemic Myocardium: Challenging Postulations And Vitality Of The Concept Of "Ischemia-Dependent Conflictogenic Arrhythmias".

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 5.  Molecular adaptations in human atrial fibrillation: mechanisms of protein remodelling.

Authors:  B J J M Brundel; R H Henning; W H van Gilst; I C van Gelder; H J G M Crijns
Journal:  Neth Heart J       Date:  2001-09       Impact factor: 2.380

Review 6.  Mechanisms of termination and prevention of atrial fibrillation by drug therapy.

Authors:  A J Workman; G L Smith; A C Rankin
Journal:  Pharmacol Ther       Date:  2011-02-18       Impact factor: 12.310

Review 7.  Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions.

Authors:  Syona S Shetty; Andrew Krumerman
Journal:  Cardiovasc Diabetol       Date:  2022-06-28       Impact factor: 8.949

8.  Acute regional left atrial ischemia causes acceleration of atrial drivers during atrial fibrillation.

Authors:  Masatoshi Yamazaki; Uma Mahesh R Avula; Krishna Bandaru; Auras Atreya; Venkata Subbarao C Boppana; Haruo Honjo; Itsuo Kodama; Kaichiro Kamiya; Jérôme Kalifa
Journal:  Heart Rhythm       Date:  2013-02-21       Impact factor: 6.343

Review 9.  Atrial Calpains: Mediators of Atrialmyopathies in Atrial Fibrillation.

Authors:  Alicja Bukowska; Uwe Lendeckel; Andreas Goette
Journal:  J Atr Fibrillation       Date:  2014-04-30

10.  Effect of eicosapentaenoic acid and pitavastatin on electrophysiology and anticoagulant gene expression in mice with rapid atrial pacing.

Authors:  Maoqing Tong; Jiewen Wang; Yunxin Ji; Xiaomin Chen; Jieru Wang; Shuangshuang Wang; Liemin Ruan; Hanbin Cui; Ying Zhou; Qingyu Zhang; Eiichi Watanabe
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.